Physician profile
Michael Knee
NPI 1225123961
$19,938.45
in general payments reported to CMS, 2019-2025
43 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,776 · 2020: $2,013 · 2021: $2,070 · 2022: $2,636 · 2023: $2,869 · 2024: $2,801 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,344 · Education: $99.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,343.53 |
| Education | $99.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,518.84 | 2019-2025 | Evenity, Krystexxa, Enbrel |
| Abbvie INC. | $2,883.79 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,567.82 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $1,291.28 | 2020-2025 | Acthar |
| Astrazeneca Pharmaceuticals Lp | $1,227.46 | 2021-2025 | Saphnelo |
| Lilly USA, LLC | $1,195.33 | 2019-2024 | Taltz, Olumiant |
| Pfizer INC. | $921.92 | 2019-2025 | |
| Janssen Biotech, INC. | $853.59 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Ucb, INC. | $715.95 | 2019-2025 | Cimzia, Bimzelx |
| Genzyme Corporation | $670.29 | 2019-2025 | |
| Aurinia Pharma U.S., INC. | $576.35 | 2021-2025 | Lupkynis |
| Horizon Therapeutics Plc | $573.81 | 2019-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $535.04 | 2019-2024 | Benlysta, Nucala |
| Genentech USA, INC. | $432.03 | 2019-2023 | Actemra |
| Radius Health, INC. | $378.59 | 2019-2025 | Tymlos |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Knee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.